In Vitro Activity of Cefaclor/Beta-Lactamases Inhibitors (Clavulanic Acid and Sulbactam) Combination Against Extended-Spectrum Beta-Lactamase Producing Uropathogenic E. coli

I tiakina i:

Ngā taipitopito rārangi puna kōrero
I whakaputaina i:	Antibiotics vol. 14, no. 6 (2025), p. 603
Kaituhi matua:	Atoom Ali
Ētahi atu kaituhi:	Alzubi Bayan, Barakat, Dana, Abu-Gheyab, Rana, Ismail-Agha, Dalia, Al-Kaabneh Awatef, Numan Nawfal
I whakaputaina:	MDPI AG
Ngā marau:	Urogenital system In vitro methods and tests Sulbactam Urinary tract Acids Public health Phenotypes Bacteria Clavulanic acid Approximation Availability E coli Amides Cefaclor Genotype & phenotype Multidrug resistance Cost effectiveness Bactericidal activity Urinary tract diseases Urinary tract infections Inhibitors Approximation method Minimum inhibitory concentration Bacterial infections Antimicrobial agents Carbapenems Global health Streptococcus infections Enzymes β Lactamase Antimicrobial activity
Urunga tuihono:	Citation/Abstract Full Text + Graphics Full Text - PDF
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!